Glück Conviction Score™ ⓘ
PTGX
Protagonist Therapeutics, Inc
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
79,5
61 neu, 109 erhöht, 2272,7M $ netto
Aktivist
28,5
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 101.61 | +8.0 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 86.45 | +27.0 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 102.13 | EMA50: 100.36 | |
| MACD-Histogramm | Bullisch | 10 % | 1.318 | Bullisch | |
| RSI(14) | Neutral | 10 % | 61.6 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 89.5 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 21.2 | +DI: 29.5 / −DI: 10.6 | |
| Z-Score(60) | Bärisch | 5 % | 2.46 | Extrem überkauft | |
| 52W-Position | Bullisch | 5 % | 100.0 % | Hoch 109.79 / Tief 49.70 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 101.3 % | Upper 109.55 / Mid 100.92 / Lower 92.30 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0135 | R²=0.00 / annualisiert -3.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | Waddill William D. | Director | Open Market Sale | -9.000 | 107,68 | -969.120,00 | -62,2% | |
| 2026-05-29 | Waddill William D. | Director | Open Market Sale | -9.000 | 99,64 | -896.760,00 | -57,6% | |
| 2026-05-12 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -75.000 | 100,12 | -7.509.000,00 | -482,0% | |
| 2026-05-12 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -75.000 | 100,12 | -7.509.000,00 | -482,0% | |
| 2026-05-08 | Giraudo Bryan | Director | Open Market Sale | -5.130 | 100,00 | -513.000,00 | -32,9% | |
| 2026-05-08 | Giraudo Bryan | Director | Open Market Sale | -6.000 | 100,00 | -600.000,00 | -38,5% | |
| 2026-05-07 | Giraudo Bryan | Director | Open Market Sale | -12.000 | 100,07 | -1.200.840,00 | -77,1% | |
| 2026-05-07 | Giraudo Bryan | Director | Open Market Sale | -36.000 | 100,14 | -3.605.040,00 | -231,4% | |
| 2026-04-20 | Ali Asif | Officer, Chief Financial Officer | Open Market Sale | -1.750 | 105,47 | -184.572,50 | -11,8% | |
| 2026-03-26 | Ali Asif | Officer, Chief Financial Officer | Open Market Sale | -24.765 | 104,24 | -2.581.503,60 | -165,7% | |
| 2026-03-26 | SELICK HAROLD E | Director | Open Market Sale | -24.000 | 105,00 | -2.520.000,00 | -161,8% | |
| 2026-03-26 | MOLINA ARTURO MD | Officer, Chief Medical Officer | Open Market Sale | -15.000 | 104,79 | -1.571.850,00 | -100,9% | |
| 2026-03-25 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -54.641 | 101,00 | -5.518.741,00 | -354,3% | |
| 2026-03-24 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -59 | 101,00 | -5.959,00 | -0,4% | |
| 2026-02-17 | Williams Lewis T | Director | Open Market Sale | -18.000 | 82,42 | -1.483.560,00 | -95,2% | |
| 2026-02-06 | Waddill William D. | Director | Open Market Sale | -20.000 | 83,68 | -1.673.600,00 | -107,4% | |
| 2026-01-27 | MOLINA ARTURO MD | Officer, Chief Medical Officer | Open Market Sale | -5.000 | 82,00 | -410.000,00 | -26,3% | |
| 2026-01-27 | Ali Asif | Officer, Chief Financial Officer | Open Market Sale | -28.000 | 83,13 | -2.327.640,00 | -149,4% | |
| 2026-01-27 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -4.068 | 83,19 | -338.416,92 | -21,7% | |
| 2026-01-27 | Ali Asif | Officer, Chief Financial Officer | Open Market Sale | -18.203 | 83,14 | -1.513.397,42 | -97,1% | |
| 2026-01-26 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -10.685 | 84,00 | -897.540,00 | -57,6% | |
| 2026-01-26 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -14.205 | 84,05 | -1.193.930,25 | -76,6% | |
| 2026-01-26 | MOLINA ARTURO MD | Officer, Chief Medical Officer | Open Market Sale | -5.000 | 82,28 | -411.400,00 | -26,4% | |
| 2026-01-23 | MOLINA ARTURO MD | Officer, Chief Medical Officer | Open Market Sale | -13.151 | 82,42 | -1.083.905,42 | -69,6% | |
| 2026-01-23 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -19.315 | 84,59 | -1.633.855,85 | -104,9% | |
| 2026-01-20 | MOLINA ARTURO MD | Officer, Chief Medical Officer | Open Market Sale | -9.514 | 82,48 | -784.714,72 | -50,4% | |
| 2026-01-20 | Ali Asif | Officer, Chief Financial Officer | Open Market Sale | -8.588 | 82,48 | -708.338,24 | -45,5% | |
| 2026-01-20 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -34.438 | 82,48 | -2.840.446,24 | -182,3% | |
| 2025-11-17 | MOLINA ARTURO MD | Officer, Chief Medical Officer | Open Market Sale | -2.712 | 84,77 | -229.896,24 | -14,8% | |
| 2025-10-10 | Waddill William D. | Director | Open Market Sale | -4.000 | 69,25 | -277.000,00 | -17,8% | |
| 2025-10-10 | Waddill William D. | Director | Open Market Sale | -8.000 | 87,81 | -702.480,00 | -45,1% | |
| 2025-09-22 | Waddill William D. | Director | Open Market Sale | -4.000 | 64,25 | -257.000,00 | -16,5% | |
| 2025-08-27 | Waddill William D. | Director | Open Market Sale | -4.000 | 59,25 | -237.000,00 | -15,2% | |
| 2025-07-25 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -10.415 | 54,78 | -570.533,70 | -36,6% | |
| 2025-07-23 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -17.520 | 54,79 | -959.920,80 | -61,6% | |
| 2025-07-22 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -22.065 | 55,05 | -1.214.678,25 | -78,0% | |
| 2025-07-21 | PATEL DINESH V PH D | Director, Officer, President and CEO | Open Market Sale | -12.859 | 54,86 | -705.444,74 | -45,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 9.779.369 | 9.715.999 | 63.370 | 1.030.745.507 | Aufgestockt | +0,7% | |
| FARALLON CAPITAL MANAGEMENT LLC | 6.348.906 | 0 | 6.348.906 | 669.174.692 | Neu | +100,0% | |
| UBS Group AG | 5.177.796 | 2.770.021 | 2.407.775 | 545.739.698 | Aufgestockt | +86,9% | |
| RTW INVESTMENTS, LP | 5.059.053 | 5.059.053 | 0 | 533.224.186 | Unverändert | 0,0% | |
| VANGUARD GROUP INC | 5.413.690 | 0 | 5.413.690 | 472.831.684 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 3.599.644 | 3.171.423 | 428.221 | 379.402.479 | Aufgestockt | +13,5% | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.481.211 | 0 | 3.481.211 | 366.919.639 | Neu | +100,0% | |
| STATE STREET CORP | 3.116.749 | 3.199.729 | -82.980 | 328.505.345 | Reduziert | -2,6% | |
| JANUS HENDERSON GROUP PLC | 2.891.527 | 2.649.981 | 241.546 | 304.866.424 | Aufgestockt | +9,1% | |
| JOHNSON & JOHNSON | 2.449.183 | 2.449.183 | 0 | 258.143.888 | Unverändert | 0,0% | |
| Invesco Ltd. | 2.164.670 | 1.567.840 | 596.830 | 228.156.218 | Aufgestockt | +38,1% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.669.371 | 1.452.928 | 216.443 | 175.982.148 | Aufgestockt | +14,9% | |
| CITADEL ADVISORS LLC | 1.604.400 | 1.221.887 | 382.513 | 169.103.760 | Aufgestockt | +31,3% | |
| Woodline Partners LP | 1.414.173 | 1.408.772 | 5.401 | 149.053.834 | Aufgestockt | +0,4% | |
| BANK OF AMERICA CORP /DE/ | 1.295.434 | 867.580 | 427.854 | 136.538.743 | Aufgestockt | +49,3% | |
| PERCEPTIVE ADVISORS LLC | 1.230.879 | 1.350.425 | -119.546 | 129.734.647 | Reduziert | -8,9% | |
| JENNISON ASSOCIATES LLC | 1.072.011 | 331.164 | 740.847 | 112.989.961 | Aufgestockt | +223,7% | |
| MORGAN STANLEY | 1.018.222 | 879.024 | 139.198 | 107.320.718 | Aufgestockt | +15,8% | |
| ADAR1 Capital Management, LLC | 994.119 | 1.049.168 | -55.049 | 104.780.143 | Reduziert | -5,2% | |
| Hood River Capital Management LLC | 829.285 | 0 | 829.285 | 87.406.639 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 778.945 | 961.149 | -182.204 | 82.100.804 | Reduziert | -19,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 720.928 | 1.099.170 | -378.242 | 75.985.811 | Reduziert | -34,4% | |
| FMR LLC | 661.997 | 539.878 | 122.119 | 69.774.496 | Aufgestockt | +22,6% | |
| MARSHALL WACE, LLP | 628.075 | 1.024.925 | -396.850 | 66.199.102 | Reduziert | -38,7% | |
| Clearbridge Investments, LLC | 621.820 | 489.842 | 131.978 | 65.539.829 | Aufgestockt | +26,9% | |
| Alyeska Investment Group, L.P. | 593.197 | 199.523 | 393.674 | 62.522.964 | Aufgestockt | +197,3% | |
| NORTHERN TRUST CORP | 587.968 | 575.118 | 12.850 | 61.971.828 | Aufgestockt | +2,2% | |
| Pictet Asset Management Holding SA | 581.083 | 529.631 | 51.452 | 61.246.148 | Aufgestockt | +9,7% | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 571.825 | 571.825 | 0 | 60.270.355 | Unverändert | 0,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 552.956 | 556.762 | -3.806 | 58.281.562 | Reduziert | -0,7% | |
| AMERICAN CENTURY COMPANIES INC | 537.320 | 535.423 | 1.897 | 56.633.738 | Aufgestockt | +0,4% | |
| DIMENSIONAL FUND ADVISORS LP | 508.103 | 414.415 | 93.688 | 53.541.525 | Aufgestockt | +22,6% | |
| VOYA INVESTMENT MANAGEMENT LLC | 454.383 | 366.165 | 88.218 | 47.891.968 | Aufgestockt | +24,1% | |
| Rubric Capital Management LP | 427.998 | 0 | 427.998 | 45.110.989 | Neu | +100,0% | |
| VANGUARD FIDUCIARY TRUST CO | 412.730 | 0 | 412.730 | 43.501.742 | Neu | +100,0% | |
| Commodore Capital LP | 450.000 | 0 | 450.000 | 39.303.000 | Neu | +100,0% | |
| 683 Capital Management, LLC | 370.100 | 430.969 | -60.869 | 39.008.540 | Reduziert | -14,1% | |
| PRINCIPAL FINANCIAL GROUP INC | 367.822 | 347.932 | 19.890 | 38.768.440 | Aufgestockt | +5,7% | |
| Vestal Point Capital, LP | 326.159 | 0 | 326.159 | 34.377.159 | Neu | +100,0% | |
| BNP Paribas Asset Management Holding S.A. | 306.037 | 330.804 | -24.767 | 32.256.300 | Reduziert | -7,5% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 282.436 | 232.836 | 49.600 | 29.768.754 | Aufgestockt | +21,3% | |
| SEB Asset Management AB | 232.416 | 0 | 232.416 | 24.496.615 | Neu | +100,0% | |
| NEXTBio Capital Management LP | 229.619 | 229.619 | 0 | 24.201.843 | Unverändert | 0,0% | |
| SEGALL BRYANT & HAMILL, LLC | 212.714 | 129.060 | 83.654 | 22.420.056 | Aufgestockt | +64,8% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 211.576 | 392.262 | -180.686 | 22.300.110 | Reduziert | -46,1% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 210.280 | 203.426 | 6.854 | 22.163.512 | Aufgestockt | +3,4% | |
| Holocene Advisors, LP | 209.916 | 210.019 | -103 | 22.125.146 | Reduziert | 0,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 194.530 | 97.764 | 96.766 | 20.503.462 | Aufgestockt | +99,0% | |
| TD ASSET MANAGEMENT INC | 183.700 | 158.730 | 24.970 | 19.361.980 | Aufgestockt | +15,7% | |
| Eagle Health Investments LP | 179.322 | 57.300 | 122.022 | 18.900.539 | Aufgestockt | +213,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.779.369 | 9.715.999 | +0,7% | 1.030.745.507 | 13,26 |
| FARALLON CAPITAL MANAGEMENT LLC | 6.348.906 | 0 | +100,0% | 669.174.692 | 8,61 |
| UBS Group AG | 5.177.796 | 2.770.021 | +86,9% | 545.739.698 | 7,02 |
| RTW INVESTMENTS, LP | 5.059.053 | 5.059.053 | 0,0% | 533.224.186 | 6,86 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.599.644 | 3.171.423 | +13,5% | 379.402.479 | 4,88 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.481.211 | 0 | +100,0% | 366.919.639 | 4,72 |
| STATE STREET CORP | 3.116.749 | 3.199.729 | -2,6% | 328.505.345 | 4,23 |
| JANUS HENDERSON GROUP PLC | 2.891.527 | 2.649.981 | +9,1% | 304.866.424 | 3,92 |
| JOHNSON & JOHNSON | 2.449.183 | 2.449.183 | 0,0% | 258.143.888 | 3,32 |
| Invesco Ltd. | 2.164.670 | 1.567.840 | +38,1% | 228.156.218 | 2,94 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.669.371 | 1.452.928 | +14,9% | 175.982.148 | 2,26 |
| CITADEL ADVISORS LLC | 1.604.400 | 1.221.887 | +31,3% | 169.103.760 | 2,18 |
| Woodline Partners LP | 1.414.173 | 1.408.772 | +0,4% | 149.053.834 | 1,92 |
| BANK OF AMERICA CORP /DE/ | 1.295.434 | 867.580 | +49,3% | 136.538.743 | 1,76 |
| PERCEPTIVE ADVISORS LLC | 1.230.879 | 1.350.425 | -8,9% | 129.734.647 | 1,67 |
| JENNISON ASSOCIATES LLC | 1.072.011 | 331.164 | +223,7% | 112.989.961 | 1,45 |
| MORGAN STANLEY | 1.018.222 | 879.024 | +15,8% | 107.320.718 | 1,38 |
| ADAR1 Capital Management, LLC | 994.119 | 1.049.168 | -5,2% | 104.780.143 | 1,35 |
| Hood River Capital Management LLC | 829.285 | 0 | +100,0% | 87.406.639 | 1,12 |
| GOLDMAN SACHS GROUP INC | 778.945 | 961.149 | -19,0% | 82.100.804 | 1,06 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 322 | 84,9 | 8.684 |
| 31.12.2025 | ✓ | 319 | 76,8 | 6.508 |
| 30.09.2025 | ✓ | 276 | 81,4 | 5.263 |
| 30.06.2025 | ✓ | 272 | 71,9 | 3.855 |
| 31.03.2025 | ✓ | 277 | 70,7 | 3.283 |
| 31.12.2024 | ✓ | 238 | 67,8 | 2.539 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 571.825 | 49.943.196 |
| Clearbridge Investments, LLC | 489.842 | 42.782.833 |
| JENNISON ASSOCIATES LLC | 331.164 | 28.923.862 |
| NEXTBio Capital Management LP | 229.619 | 20.054.923 |
| Holocene Advisors, LP | 210.019 | 18.343.059 |
| Alyeska Investment Group, L.P. | 199.523 | 17.426.339 |
| MPM BioImpact LLC | 199.471 | 17.421.797 |
| AIHC Capital Management Ltd | 189.823 | 16.579.141 |
| Qube Research & Technologies Ltd | 153.876 | 13.439.530 |
| Hudson Bay Capital Management LP | 109.615 | 9.573.774 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 2.649.981 | 1.549.160 | +140.7 % | 231.354.837 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.171.423 | 1.262.977 | +66.2 % | 276.992.086 |
| VANGUARD GROUP INC | 5.413.690 | 1.156.461 | +27.2 % | 472.831.684 |
| CITADEL ADVISORS LLC | 1.221.887 | 952.606 | +353.8 % | 106.719.610 |
| UBS Group AG | 2.770.021 | 874.013 | +46.1 % | 241.933.634 |
| Invesco Ltd. | 1.567.840 | 564.134 | +56.2 % | 136.935.146 |
| PERCEPTIVE ADVISORS LLC | 1.350.425 | 320.291 | +31.1 % | 117.946.120 |
| BlackRock, Inc. | 9.715.999 | 311.767 | +3.3 % | 848.595.367 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 392.262 | 226.074 | +136.0 % | 34.260.163 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.400.738 | 180.302 | +14.8 % | 122.341 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Jefferies Financial Group Inc. | 5.000 | -816.503 | -99.4 % | 436.700 |
| RTW INVESTMENTS, LP | 5.059.053 | -697.224 | -12.1 % | 441.857.689 |
| Commodore Capital LP | 450.000 | -575.000 | -56.1 % | 39.303.000 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 232.836 | -485.366 | -67.6 % | 20.335.896 |
| TORONTO DOMINION BANK | 21.500 | -423.940 | -95.2 % | 1.877.810 |
| Pictet Asset Management Holding SA | 529.631 | -292.581 | -35.6 % | 46.257.972 |
| ALLIANCEBERNSTEIN L.P. | 73.222 | -187.632 | -71.9 % | 6.395.209 |
| BNP Paribas Asset Management Holding S.A. | 330.804 | -120.962 | -26.8 % | 28.893 |
| RAYMOND JAMES FINANCIAL INC | 181.503 | -112.793 | -38.3 % | 15.838.951 |
| MILLENNIUM MANAGEMENT LLC | 17.391 | -110.169 | -86.4 % | 1.518.930 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 12.05.2026 | STATE STREET CORPORATION | Passiv (13G) | 4,90 % | 3.116.804 | -0,30 pp | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,09 % | 3.250.003 | Neu | |
| 29.04.2026 | Vanguard Portfolio Management | Passiv (13G) | 5,53 % | 3.533.015 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -8,65 pp | |
| 17.02.2026 | Roderick Wong | Passiv (13G/A) | 8,10 % | 5.059.053 | +0,80 pp | |
| 17.02.2026 | RTW Investments, LP | Passiv (13G/A) | 8,10 % | 5.059.053 | -1,10 pp | |
| 10.02.2026 | Wellington Investment Advisors Holdings LLP | Passiv (13G) | 5,10 % | 3.171.423 | Neu | |
| 10.02.2026 | Wellington Management Group LLP | Passiv (13G) | 5,10 % | 3.171.423 | Neu | |
| 10.02.2026 | Wellington Group Holdings LLP | Passiv (13G) | 5,10 % | 3.171.423 | Neu | |
| 06.02.2026 | Roberts, Jr., Thomas G. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Four Crossings Institutional Partners V, L.P. | Passiv (13G/A) | 0,10 % | 53.343 | 0,00 pp | |
| 06.02.2026 | Linn, Michael G. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Farallon Partners, L.L.C. | Passiv (13G/A) | 9,80 % | 6.126.919 | 0,00 pp | |
| 06.02.2026 | Patel, Rajiv A. | Passiv (13G/A) | Ausstieg | 0 | -9,99 pp | |
| 06.02.2026 | Farallon Healthcare Partners Master, L.P. | Passiv (13G/A) | 7,60 % | 4.767.564 | +0,20 pp | |
| 06.02.2026 | Wehrly, Mark C. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Dunn Hannah E. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Giauque, Nicolas | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Farallon Capital Partners, L.P. | Passiv (13G/A) | 0,50 % | 283.062 | 0,00 pp | |
| 06.02.2026 | Kim, David T. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Warren, John R. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Husen, Avner A. | Passiv (13G/A) | 9,99 % | 6.248.013 | Neu | |
| 06.02.2026 | Short Daniel S. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Gehani, Varun N. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Farallon Capital Institutional Partners III, L.P. | Passiv (13G/A) | 0,10 % | 39.417 | 0,00 pp | |
| 06.02.2026 | Dapice Joshua J. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Farallon Capital F5 Master I, L.P. | Passiv (13G/A) | 0,20 % | 121.094 | 0,00 pp | |
| 06.02.2026 | Farallon Healthcare Partners (GP), L.L.C. | Passiv (13G/A) | 7,60 % | 4.767.564 | +0,20 pp | |
| 06.02.2026 | Luo Patrick (Cheng) | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Farallon F5 (GP), L.L.C. | Passiv (13G/A) | 0,20 % | 121.094 | 0,00 pp | |
| 06.02.2026 | Spokes, Andrew J. M. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Farallon Institutional (GP) V, L.L.C. | Passiv (13G/A) | 0,10 % | 53.343 | 0,00 pp | |
| 06.02.2026 | Saito Edric C. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Fried, Richard B | Passiv (13G/A) | Ausstieg | 0 | -9,99 pp | |
| 06.02.2026 | Farallon Capital Institutional Partners, L.P. | Passiv (13G/A) | 0,50 % | 290.850 | 0,00 pp | |
| 06.02.2026 | Farallon Capital Institutional Partners II, L.P. | Passiv (13G/A) | 0,10 % | 91.421 | -0,10 pp | |
| 06.02.2026 | Dreyfuss, Philip D. | Passiv (13G/A) | 9,99 % | 6.248.013 | 0,00 pp | |
| 06.02.2026 | Seybold, William | Passiv (13G/A) | Ausstieg | 0 | -9,99 pp | |
| 06.02.2026 | Farallon Capital Offshore Investors II, L.P. | Passiv (13G/A) | 0,90 % | 565.080 | -0,10 pp | |
| 06.02.2026 | Farallon Capital (AM) Investors, L.P. | Passiv (13G/A) | 0,10 % | 36.181 | 0,00 pp |
Stammdaten
Protagonist Therapeutics, Inc., ein Biopharmaunternehmen, entdeckt und entwickelt Peptid-basierte Arzneimittel zur Behandlung von Hämatologie und Bluterkrankungen sowie entzündlichen und immunmodulatorischen Erkrankungen. Das Unternehmen entwickelt Rusfertide (PTG-300), ein injizierbares Hepcidin-Mimetikum, das sich in Phase-II-Studien für die Behandlung von Patienten mit Polycythaemia vera und hereditärer Hämochromatose befindet, sowie für die Behandlung anderer Bluterkrankungen; PN-943, ein orales Alpha-4-Beta-7-Integrin-spezifisches Antagonist-Peptid, das sich in Phase-II-Studien für die Behandlung von entzündlicher Darmerkrankung (IBD) befindet; und PN-235, ein oral verabreichtes Interleukin-23-Rezeptor-spezifisches Antagonist-Peptid zur Behandlung von IBD und nicht-IBD-Indikationen. Das Unternehmen hat eine Lizenz- und Kooperationsvereinbarung mit Janssen Biotech, Inc. Protagonist Therapeutics, Inc. wurde 2006 gegründet und hat seinen Hauptsitz in Newark, Kalifornien.
Unternehmen & Branche
| Name | Protagonist Therapeutics, Inc |
|---|---|
| Ticker | PTGX |
| CIK | 0001377121 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 74366E102 |
|---|---|
| ISIN | US74366E1029 |
| Typ | Common Stock |
| Marktkapitalisierung | 6,88 Mrd. USD |
| Beta | 1,84 |
Bewertung
| KBV (P/B) | 11,20 vs. 5,45 (2021) ▲ |
|---|---|
| FCF-Rendite | 0,8 % vs. -6,7 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -20,8 % vs. -41,0 % (2021) ▲ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 5,45 | 2,50 | 3,93 | 3,49 | 8,89 | |
| FCF-Rendite | -6,7 % | -20,2 % | -5,4 % | 7,8 % | 1,0 % | |
| Qualität & Bilanz | ||||||
| ROIC | -41,0 % | -58,1 % | -23,5 % | 40,1 % | -20,8 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 3.783.000 | 0,05 | 697.459.000 | 655.473.000 | |
| 2025-12-31 | 10-K | -130.149.000 | -2,05 | 668.188.000 | 614.707.000 | |
| 2025-09-30 | 10-Q | -39.339.000 | -0,62 | 701.688.000 | 645.437.000 | |
| 2025-06-30 | 10-Q | -34.771.000 | -0,55 | 718.006.000 | 668.018.000 | |
| 2025-03-31 | 10-Q | -11.655.000 | -0,19 | 742.132.000 | 689.052.000 | |
| 2024-12-31 | 10-K | 275.188.000 | 4,23 | 744.725.000 | 675.295.000 | |
| 2024-09-30 | 10-Q | -33.210.000 | -0,54 | 603.857.000 | 531.915.000 | |
| 2024-06-30 | 10-Q | -30.616.000 | -0,50 | 614.629.000 | 541.324.000 | |
| 2024-03-31 | 10-Q | 207.340.000 | 3,26 | 629.276.000 | 560.444.000 | |
| 2023-12-31 | 10-K | -78.955.000 | -1,39 | 357.951.000 | 336.677.000 | |
| 2023-09-30 | 10-Q | -34.105.000 | -0,58 | 330.016.000 | 302.149.000 | |
| 2023-06-30 | 10-Q | -38.460.000 | -0,68 | 320.466.000 | 294.068.000 | |
| 2023-03-31 | 10-Q | -33.725.000 | -0,67 | 239.858.000 | 216.167.000 | |
| 2022-12-31 | 10-K | -127.393.000 | -2,60 | 247.928.000 | 215.608.000 | |
| 2022-09-30 | 10-Q | -31.232.000 | -0,64 | 282.174.000 | 243.616.000 | |
| 2022-06-30 | 10-Q | -41.037.000 | -0,84 | 310.512.000 | 267.978.000 | |
| 2022-03-31 | 10-Q | -20.930.000 | -0,43 | 348.296.000 | 301.778.000 | |
| 2021-12-31 | 10-K | -125.551.000 | -2,71 | 347.695.000 | 300.021.000 | |
| 2021-09-30 | 10-Q | -33.804.000 | -0,70 | 373.175.000 | 329.660.000 | |
| 2021-06-30 | 10-Q | -30.842.000 | -0,69 | 404.232.000 | 357.447.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 05.05.2026 | – | 0,05 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | – | -0,62 |
| Q2 2025 | 30.06.2025 | 06.08.2025 | – | -0,55 |
| Q1 2025 | 31.03.2025 | 05.05.2026 | – | -0,19 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | – | -0,54 |
| Q2 2024 | 30.06.2024 | 06.08.2025 | – | -0,50 |
| Q1 2024 | 31.03.2024 | 06.05.2025 | – | 3,26 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | – | -0,58 |
| Q2 2023 | 30.06.2023 | 06.08.2024 | – | -0,68 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 05.05.2026 | 10-Q | 31.03.2026 | 35 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 21.02.2025 | 10-K | 31.12.2024 | 52 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 06.08.2024 | 10-Q | 30.06.2024 | 37 Tage | SEC » |
| 07.05.2024 | 10-Q | 31.03.2024 | 37 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 02.11.2023 | 10-Q | 30.09.2023 | 33 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 04.05.2023 | 10-Q | 31.03.2023 | 34 Tage | SEC » |
| 15.03.2023 | 10-K | 31.12.2022 | 74 Tage | SEC » |
| 08.11.2022 | 10-Q | 30.09.2022 | 39 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 03.11.2021 | 10-Q | 30.09.2021 | 34 Tage | SEC » |
| 04.08.2021 | 10-Q | 30.06.2021 | 35 Tage | SEC » |
| 04.05.2021 | 10-Q | 31.03.2021 | 34 Tage | SEC » |
| 10.03.2021 | 10-K | 31.12.2020 | 69 Tage | SEC » |
| 04.11.2020 | 10-Q | 30.09.2020 | 35 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 30.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointments of Certain… |
| 02.10.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.08.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-12 | 10.792 | 103,50 | 1.116.972 |
| 2026-05-11 | 50 | 99,36 | 4.968 |
| 2026-05-08 | 31.241 | 98,85 | 3.088.173 |
| 2026-04-30 | 96 | 98,52 | 9.458 |
| 2026-04-23 | 27.974 | 105,55 | 2.952.656 |
| 2026-04-22 | 167.374 | 105,89 | 17.723.233 |
| 2026-04-21 | 5.489 | 105,47 | 578.925 |
| 2026-04-17 | 20.360 | 103,73 | 2.111.943 |
| 2026-03-23 | 6 | 98,87 | 593 |
| 2026-03-19 | 100 | 97,09 | 9.709 |
| 2026-03-17 | 10 | 96,75 | 968 |
| 2026-03-04 | 9.288 | 91,30 | 847.994 |
| 2026-03-02 | 4.764 | 92,08 | 438.669 |
| 2026-02-27 | 6.327 | 88,39 | 559.244 |
| 2026-02-25 | 584 | 87,39 | 51.036 |
| 2026-02-20 | 488 | 83,09 | 40.548 |
| 2026-02-19 | 43 | 82,99 | 3.569 |
| 2026-02-13 | 17 | 81,93 | 1.393 |
| 2026-02-09 | 8 | 84,49 | 676 |
| 2026-02-04 | 92 | 85,59 | 7.874 |
| 2026-01-28 | 19.014 | 83,08 | 1.579.683 |
| 2026-01-21 | 39.380 | 83,42 | 3.285.080 |
| 2026-01-15 | 745 | 85,23 | 63.496 |
| 2026-01-13 | 44 | 80,25 | 3.531 |
| 2026-01-09 | 9 | 80,20 | 722 |
| 2026-01-06 | 560 | 84,18 | 47.141 |
| 2025-12-31 | 30 | 87,26 | 2.618 |
| 2025-12-15 | 1.649 | 95,35 | 157.232 |